Description du projet
Une plateforme innovante pour un suivi précis, efficace et exploitable des patients souffrant d’insuffisance cardiaque
L’insuffisance cardiaque (IC) est l’une des maladies chroniques que la médecine peine à prévenir, à diagnostiquer et à traiter efficacement. Pourtant, elle reste la première cause mondiale d’invalidité et de décès prématuré. Il est indispensable de réduire considérablement le nombre d’hospitalisations afin de maintenir la qualité de vie des patients et d’amoindrir son impact sur l’efficacité de l’ensemble du système de santé. Le projet RETENTION, financé par l’UE, vise à développer une plateforme innovante pour faciliter la prise de décision clinique et les interventions personnalisées fondées sur des données probantes pour les patients atteints d’IC. Grâce à la collecte et à l’analyse automatisées des données des patients, cette solution innovante visera à réduire la mortalité parmi les patients et à améliorer leur qualité de vie.
Objectif
Heart failure (HF) is a prominent chronic disease, despite efforts in improving its prevention, diagnosis and treatment, represents the leading cause of disability and premature death throughout the world, while being is a heavy burden on health systems due to the multiple, prolonged hospitalizations required for patients suffering from it and the related management costs. Nevertheless, studies have shown that routine patient-physician or patient-nurse communication following discharge can result in significant reduction of hospitalizations. The pertinent collected patient data may include simple yet important information (e.g. patient weight), as well as previously difficult to obtain information such as routine ECG, ICD/CRT-D interrogation and pulmonary arterial pressure monitoring, which are now within reach due to technological progress. Motivated by the above, RETENTION aims to develop and deliver an innovative platform supporting enhanced clinical monitoring and interventions aimed at improving the clinical management of patients with chronic HF, reducing their mortality and hospitalisation rates, and improving their quality of life, safety, and well-being. The RETENTION platform will support clinical decision making and evidenced based personalised interventions for HF patients by: (a) continually monitoring and collecting medical, clinical, physiological, behavioural, psychosocial, and real-world data for such patients, (b) analysing these data using innovative model-driven big data analytics, statistical, artificial intelligence and machine learning techniques, (c) detecting patterns in the HF disease progression and the quality of life of patients, (d) cross checking and validating them against the clinical literature, and (e) offering transparent, explainable and verifiable decision making capabilities that leverage the evidence produced by the underlying data analysis and augment clinical studies targeting HF and other CVDs.
Champ scientifique
Mots‑clés
Programme(s)
Régime de financement
RIA - Research and Innovation actionCoordinateur
106 82 ATHINA
Grèce